Back
57· Steady
Health & Science2h 30m ago
A new study suggests that overstimulating key cancer-growth pathways, rather than shutting them down, could offer a novel way to target pancreatic tumors driven by KRAS mutations.
Tallahassee, Florida
Who
Kweku Ofosu-Asante, Nazarius S. Lamango of the Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
What
A new study suggests that overstimulating key cancer-growth pathways, rather than shutting them down, could offer a novel way to target pancreatic tumors driven by KRAS mutations.
When
Tue, 16 Jun 2026 15:26:58 GMT · 2h 30m ago
Where
Tallahassee, Florida ·
Why
This research addresses a major gap in KRAS-targeted treatments for pancreatic cancer, as current therapies mainly work against one specific KRAS mutation, leaving many patients without effective options.
The Frontline Impact
How this affects you
The study's findings, though early and not yet tested in patients, could lead to new treatments for pancreatic cancer, a highly aggressive disease with limited effective therapies, potentially improving outcomes for those with KRAS mutations.
Story chain
1 event in this threadNo related history yet - this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.